Securing America’s Medicines and Supply (SAMS)

SAMS is a multi-industry coalition of companies with the mission to strengthen the security of the medical supply chain in the United States.

Become A Member
Introduction

SAMS seeks a holistic approach to restoring domestic manufacturing of medical products, one that integrates economic, regulatory, and strategic initiatives essential to securing a resilient U.S. healthcare supply chain. Only a coordinated, whole-of-government approach can effectively address the root causes of shortages and quality risks, particularly the unfavorable market conditions confronting generic and essential drug manufacturers. Specific policy initiatives include:

Supply Chain Mapping & Strategic Planning

  • Develop a comprehensive understanding of current supply chains and set priorities for rebuilding U.S. manufacturing capacity.

Federal Investment & Incentives

  • Provide targeted funding for facilities, raw materials, and workforce development, along with de-risking measures such as direct investments and strategic incentives for U.S.-based production.

Public-Private Partnerships & Reserves

  • Establish pilot programs for strategic reserves of essential medicines, leveraging vendor-managed inventory and logistics expertise to improve emergency preparedness.

Market Sustainability & Competitiveness

  • Reform trade and tax policies to eliminate structural disadvantages, prioritize U.S.-made products in government procurement, and create long-term CMS-driven incentives to retain and onshore critical medicines.

Transparency & Quality Assurance

  • Implement clear regulations on product origin and quality to build public confidence and strengthen national health security.
Members
The API Innovation Center
The API Innovation Center is a non-profit public benefit organization dedicated to delivering a market-competitive commercial supply of U.S.-made active pharmaceutical ingredients (APIs) to meet healthcare supply chain needs. Its mission is to drive health security and economic growth for the nation and its citizens through the domestic production of critical medicines.
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc., globally headquartered in Bridgewater, NJ, is a fully integrated essential medicines company with a diverse portfolio of approximately 250 products in its Generics, Biosimilar and Specialty segments and a significant domestic manufacturing base. Through its AvKARE segment, the Company is a leading distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets.
Cencora
Cencora (formerly known as AmerisourceBergen) is a leading pharmaceutical distribution and healthcare solutions organization driving innovative partnerships with manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain. With global headquarters in Conshohocken, PA, Cencora partners with pharmaceutical innovators across the supply chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions.
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals is a global pharmaceutical company headquartered in Tel Aviv, Israel that specializes in the manufacture of generic drugs, research and development of novel therapies and pharmaceutical distribution. Teva is the largest generic drug manufacturer in the world, with manufacturing facilities concentrated in the United States, Europe, and Israel. Anda, a wholly-owned subsidiary of Teva, is the fourth-largest drug distributor in the United States. 
Par Health
Par Health is the essential pharmaceutical company. We develop high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs), supported by a robust, U.S.-advantaged manufacturing network. With over 4,000 team members worldwide, we believe great healthcare is built on getting the essentials right.
Board of Directors
Maryll W. Toufanian
SAMS Chair
Senior Vice President – Regulatory Strategy and Government Affairs, Amneal Pharmaceuticals
Maryll W. Toufanian is Senior Vice President –Regulatory Strategy and Government Affairs at Amneal where she leads the company’s efforts to develop top-level regulatory strategies and Amneal’s government relations and public policy interface with state and federal policymakers. An attorney by training, Maryll has been in the accessible medicines sector for over 24 years, which tenure includes 14 years at the Food and Drug Administration in various leadership roles in the Center for Drug Evaluation & Research and the Office of the Commissioner.
Michael Brzica
SAMS Treasurer
Vice President of Government Affairs, Teva Pharmaceuticals
Michael Brzica is currently Vice President, Government Affairs for Teva Pharmaceuticals. In this role, Brzica leads the company’s interface with state and federal policymakers in legislative and executive branches. Prior to joining Teva, Brzica held roles of increasing responsibility at the Association for Accessible Medicines, a Washington, D.C. trade association representing manufacturers of generic and biosimilar medicines. In addition to these roles, Brzica worked in government affairs capacities at Prime Therapeutics and the American Dental Association. He began his career in Washington as counsel to former U.S. Representative Lee Terry (R-NE). Brzica holds a B.S. and J.D. from Creighton University in Omaha, Nebraska and currently resides in Alexandria, Virginia with his wife Lindsey, their son Henry, and dog Morris.
Andrew Gonce
SAMS Director
Chief Operations Officer, Par Health
Andrew is Chief Operations Officer for Par Health, a company formed from the 150+ year legacy of Mallinckrodt Specialty Generics and the generics and steriles business of Endo Pharmaceuticals. He is responsible for manufacturing, supply chain, procurement, and technical operations for ten manufacturing sites and over 200 products. Par Health operates seven US-based manufacturing locations, and is unique in its domestic integration of large-scale API, solid dose, and sterile production capabilities. Prior to this role, he worked in strategy, operations, and quality at Mallinckrodt, Mundipharma, Hospira, and McKinsey & Co. Over his 20-year career, he has worked across 20+ pharmaceutical plants on four continents. He has an MBA from the University of Virginia, and a Master and Bachelors in Engineering from Duke University and currently lives in Raleigh, NC.
Gerren McHam
SAMS Board Member
Vice President of Government & External Affairs, The API Center
Gerren McHam is Vice President of Government & External Affairs at the API Innovation Center, leading engagement with government, industry, and workforce partners to advance U.S. production of critical medicines. With over 15 years of experience in federal and state government on healthcare, workforce development, and education policy, he has served as a legislative aide to former U.S. Senator Jim DeMint (R-SC), Special Advisor at the U.S. Department of Education, and Director of External Relations for the Missouri Department of Higher Education and Workforce Development.
Beth Mitchell
SAMS Board Member
Vice President, U.S. Public Policy & Advocacy, Cencora
Beth Mitchell serves as Vice President, U.S. Public Policy and Advocacy at Cencora where she leads the company’s government relations and policy engagement with U.S. lawmakers, leads Cencora’s Washington, D.C. office and manages a team of federal and state advocacy, political operations, and public policy professionals. Beth has over 11 years of experience with the company. With more than 15 years in the healthcare industry and in addition to her government policy and advocacy experience, Beth also worked in sales for Daiichi-Sankyo and Sanofi. Beth served as a Policy Advisor at the law firm Nossaman LLP and began her career on Capitol Hill working for U.S. Senator Elizabeth Dole (R-NC) in Washington, D.C. Beth holds a B.S. in Business Administration with a Marketing Concentration from North Carolina State University in Raleigh, North Carolina.

Become a Member

Please contact us if you’re interested in becoming a member of SAMS.
Name(Required)
Get SAMS News